Exalys Therapeutics


Exalys Therapeutics is developing a portfolio of novel anti-inflammatory therapeutics with best-in-class properties to target a range of diseases with urgent unmet needs and limited treatment options.

Employees

11-50

Links


Org chart

Collapse
Julien Mamet
Chief Scientific Officer
Shashidhar Kori
Chief Medical Officer
Lynne Rollins
Chief Financial Officer
William Martin
EVP, Corporate Development & Operations

Board & advisors



Offices

This company has no offices yet